Please login to the form below

Not currently logged in
Email:
Password:

Orion

This page shows the latest Orion news and features for those working in and with pharma, biotech and healthcare.

UK’s NICE recommends anti-cholesterol Leqvio for high-risk patients

UK’s NICE recommends anti-cholesterol Leqvio for high-risk patients

Professor Kausik Ray of Imperial College London, who was lead investigator on the pivotal ORION-10 and ORION-11 trials for Leqvio, said that the drug brought LDL-C levels down

Latest news

More from news
Approximately 2 fully matching, plus 34 partially matching documents found.

Latest Intelligence

  • Deal Watch table for June 2014 Deal Watch table for June 2014

    75. Orion/ Bayer. Co-development, option to co-promote in Europe. OraQuick HCV rapid test in US.

  • Pharma deals during June 2014 Pharma deals during June 2014

    Financial terms were not disclosed but include milestone and royalties. Staying with the mid-caps and turning to prostate cancer, Bayer and Orion entered into a joint development deal for ... The companies will jointly fund the phase III trials. Orion

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Orion appoints VP of oncology, R&D Orion appoints VP of oncology, R&D

    He said: “My new position at Orion allows me to maintain and deepen my research focus, which is to develop such treatments for cancer patients wherever they live. ... I hope that my long background in the academia will help in the initiation of new

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...